Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives

BACKGROUND: A 12-dose, once-weekly regimen of isoniazid and rifapentine (3HP) is effective in preventing tuberculosis (TB) among people living with HIV (PLHIV). We sought to identify potential barriers to and facilitators of acceptance and completion of 3HP treatment from the perspective of people l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Implement Sci Commun
Main Authors: Semitala, Fred C., Musinguzi, Allan, Ssemata, Jackie, Welishe, Fred, Nabunje, Juliet, Kadota, Jillian L., Berger, Christopher A., Katamba, Achilles, Kiwanuka, Noah, Kamya, Moses R., Dowdy, David, Cattamanchi, Adithya, Katahoire, Anne R.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8247167/
https://ncbi.nlm.nih.gov/pubmed/34193311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s43058-021-00173-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados